1535, scurvy, which was prevalent in the French expedition trapped in Quebec, Canada, was rescued after taking the soup boiled by Indians with pine needles.
65438-0900, Journal of American Chemical Society and Journal of German Chemical Society published papers on free radicals at the same time.
1947, Jack Muskell, Ph.D. in Chemistry and Medicine, University of Bordeaux, France, discovered that there is a substance called OPC in the coating of peanuts, which has many medical and health care functions.
1949, Jack Masquelier, the father of OPC, confirmed that the pine needles that saved the French fleet more than 300 years ago were rich in OPC.
1970, the French Patent Office approved Jack Masquelier's OPC patent application with the patent number of 2092743.
1978, scientists have confirmed that free radicals are harmful to health.
From 65438 to 0986, the anti-free radical ability of OPC is 20 times that of vitamin C and 50 times that of vitamin E, which has been tested by FDA.
1987, the U.S. Patent Office approved Jack Masquelier's OPC patent application with the patent number of 4698360. In the same year, he obtained an Italian patent.
From 65438 to 0995, human beings successfully concentrated OPC extracted from 2000 grape seeds into prozac capsules with high technology. As a result, Prozac (OPC), an anti-free radical health care product, which is natural, safe, high in utilization rate and can pass the blood-brain barrier, has been officially listed in Western Europe and North America.
During the period of 1996, China's environmental pollution problems ranked among the top ten in the world, and pollution led to the accumulation of free radicals in human body. China government actively takes various measures to control the environment.
1997 People's Republic of China (PRC) and the Ministry of Health of the People's Republic of China approved Opal as the imported 089 health care product.